Table 3 Treatment use by subtype (n = 50). Results are presented as x/n (%), where x is the number of participants reporting use and n is the total number of participants. Only the index review LIS of each participant is considered
From: Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study
Treatment | Overall | RDEB-S | RDEB-I | RDEB-Inv | RDEB-Pru |
|---|---|---|---|---|---|
Emollient without menthol | 12/50 (24) | 4/20 (20) | 3/18 (17) | 3/9 (33) | 2/3 (67) |
Emollient with menthol | 2/50 (4) | 0/20 (0) | 1/18 (6) | 1/9 (11) | 0/3 (0) |
Corticosteroid | 1/50 (2) | 1/20 (5) | 0/18 (0) | 0/9 (0) | 0/3 (0) |
Antihistamine | 14/50 (28) | 9/20 (45) | 2/18 (11) | 1/9 (11) | 2/3 (67) |